Mukta Chakraborty

WORK HISTORY

EDUCATION

ABOUT MUKTA CHAKRABORTY

Neuroscientist with 16 years of academic research experience in interdisciplinary biomedical research specializing in neuroengineering brain circuits to understand cortical-basal ganglia dysfunction, and additional experience in behavioral neuroscience, neuroendocrinology, immunology, gene editing, virology, and molecular biology.Most recently employed at Ionis Pharmaceuticals Inc. as Director in Clinical Development, Neurology to provide clinical leadership in one or more clinical projects to ensure the successful design and implementation of clinical development plans.Proven leadership in medical monitoring and/or clinical trial design and execution in neurology, oncology, psychiatry, endocrinology, rare pediatric growth disorders, skeletal dysplasia, ophthalmology, and respiratory diseases.• Academic experience includes leadership roles as principal investigator (PI) for large-scale research projects, authoring many peer-reviewed scientific articles. • Extensive experience in federal grant writing, mentoring students and postdoctoral fellows conference presentations and invited guest lectures, scientific review of manuscripts for peer-reviewed journals, statistical analysis and study design, and programming.Currently serve on the National Science Foundation (NSF) panel as grant reviewer.Previously employed at Ascendis Pharma Inc. as Associate Director in Clinical Science supporting clinical development activities in the Department of Clinical Development, Endocrine Medical Sciences. • Authoring, design, strategy, and execution of clinical protocols, leading to clinical development plans for regulatory approval and market access, safety monitoring, regulatory writing, clinical data review analysis, leadership in KOL and advisory board management.Previously employed at PRA Health Sciences as Clinical Research Scientist, on contract with Merck on late-stage Oncology (Ph3) Non-Small Cell Lung Cancer (NSCLC) studies. • Scientific execution of protocol, leading medical monitoring and data review, providing scientific and clinical guidance on conduct and design of clinical trials authoring protocols, IB, amendments, safety reports, CSR. Previously employed at Syneos Health working on global (Phases I-IV) clinical studies as a Medical Scientist/Medical Project Manager in neurology, psychiatry, oncology, vaccines, and ophthalmology. • Strategic medical leadership in client relationships, medical monitoring of clinical trials and patient safety, medical review of data and reporting on data trends, financial planning, managing DSMB.